Provenance du réseau au premier degré de Peter Hwang
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Vaximm AG
 Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland.
2
| Subsidiary | Miscellaneous Commercial Services | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Peter Hwang via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
BCM Europe AG
 BCM Europe AG Investment ManagersFinance BCM Europe AG provides investment and financial advisory services. The private company is based in Zug, Switzerland and has subsidiaries in Switzerland. Guk-Hyun Hwang has been the CEO of the Swiss company since 2020. | Investment Managers | Director/Board Member Chief Executive Officer | |
CasperLabs Holdings AG
 CasperLabs Holdings AG Packaged SoftwareTechnology Services Casperlabs LLC develops block chain platform. The company was founded by Medha Parlikar, Vlad Zamfir, Steven Nerayoff and Mrinal Manohar and is headquartered in Zug, Switzerland. | Packaged Software | Director/Board Member | |
| BELLEVUE LIFE SCIENCES ACQUISITION CORP. | Financial Conglomerates | Chief Executive Officer | |
| Bellevue Capital Management LLC | Founder | ||
OSR Holdings Co., Ltd.
 OSR Holdings Co., Ltd. Pharmaceuticals: MajorHealth Technology OSR Holdings Co., Ltd. is a South Korean healthcare company that develops and licenses innovative biomedical therapies based on proprietary platform technologies to address unmet medical needs. The private company is based in an undisclosed location. The company wholly-owns three operating subsidiaries focused on developing therapeutic drugs in the areas of oncology and osteoarthritis, and the third is a distributor of medical devices for the treatment of neurovascular and other diseases. OSR Holdings signed a letter of intent to acquire Landmark Bioventures AG, a Swiss company that operates through four different biotech ventures with therapeutic focuses on oncology and immunology. The company was founded in 2019, and the CEO is Sean Chung. | Pharmaceuticals: Major | Chief Executive Officer | |
| Korea University | College/University | Undergraduate Degree |
Statistiques
Internationale
| Suisse | 3 |
| Etats-Unis | 3 |
| Corée du Sud | 3 |
Sectorielle
| Finance | 3 |
| Technology Services | 2 |
| Health Technology | 2 |
| Consumer Services | 2 |
Opérationnelle
| Director/Board Member | 5 |
| Chief Executive Officer | 3 |
| Chairman | 2 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Relations les plus connectées
| Insiders | |
|---|---|
| Guk-Hyun Hwang | 6 |
| Ralf Kubli | 3 |
- Bourse
- Insiders
- Peter Hwang
- Connexions Sociétés
